Related references
Note: Only part of the references are listed.Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells
Simon J. Dovedi et al.
CANCER DISCOVERY (2021)
FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity
Matthew Kraman et al.
CLINICAL CANCER RESEARCH (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
Targeting natural killer cells in solid tumors
Guillaume Habif et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
The NKG2A immune checkpoint - a new direction in cancer immunotherapy
Benjamin C. Creelan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue et al.
CANCER SCIENCE (2019)
A review of bispecific antibodies and antibody constructs in oncology and clinical challenges
Frans V. Suurs et al.
PHARMACOLOGY & THERAPEUTICS (2019)
The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
Anne Mansson Kvarnhammar et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Characterization and Comparison of GITR Expression in Solid Tumors
Luis Vence et al.
CLINICAL CANCER RESEARCH (2019)
Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer
James Clarke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
Lawrence P. Andrews et al.
NATURE IMMUNOLOGY (2019)
Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets
Anna C. Belkina et al.
NATURE COMMUNICATIONS (2019)
Double Positive CD4+ CD8+ T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization
Perrine Bohner et al.
FRONTIERS IN IMMUNOLOGY (2019)
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Elham Azizi et al.
CELL (2018)
Expression of CCR6 and CXCR6 by Gut-Derived CD4+/CD8α+ T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases
Emmanuelle Godefroy et al.
GASTROENTEROLOGY (2018)
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Thomas Duhen et al.
NATURE COMMUNICATIONS (2018)
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
Nadine van Montfoort et al.
CELL (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+T Cells With Expression of Exhaustion Markers
Laurence C. Menard et al.
FRONTIERS IN IMMUNOLOGY (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8(+) T Cells
Fernando P. Canale et al.
CANCER RESEARCH (2018)
Human CD39hi regulatory T cells present stronger stability and function under inflammatory conditions
Jian Gu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential
Natalie J. Tigue et al.
ONCOIMMUNOLOGY (2017)
Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8+ T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression
Meimei Bu et al.
TUMOR BIOLOGY (2016)
flowAI: automatic and interactive anomaly discerning tools for flow cytometry data
Gianni Monaco et al.
BIOINFORMATICS (2016)
Rationale for anti-GITR cancer immunotherapy
Deborah A. Knee et al.
EUROPEAN JOURNAL OF CANCER (2016)
Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
Marco De Simone et al.
IMMUNITY (2016)
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
George Plitas et al.
IMMUNITY (2016)
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito et al.
NATURE MEDICINE (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Immunosurveillance and therapy of multiple myeloma are CD226 dependent
Camille Guillerey et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, 0X40, GITR, CD27, CD28, and ICOS
Miguel F. Sanmamed et al.
SEMINARS IN ONCOLOGY (2015)
NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
Wei Wang et al.
FRONTIERS IN IMMUNOLOGY (2015)
Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival
Edith M. G. van Esch et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
CD4CD8aa Lymphocytes, A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease
Guillaume Sarrabayrouse et al.
PLOS BIOLOGY (2014)
Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients
H-B Jie et al.
BRITISH JOURNAL OF CANCER (2013)
TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
Kaori Sakuishi et al.
ONCOIMMUNOLOGY (2013)
Phenotypic and functional characteristics of CD4+CD39+FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in cancer patients
Patrick J. Schuler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression
Celine Bossard et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Tumor-reactive CD4+CD8αβ+ CD103+ αβT cells: a prevalent tumor-reactive T-cell subset in metastatic colorectal cancers
Guillaume Sarrabayrouse et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets
Patrick J. Schuler et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
Marloes Gooden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype
K. M. Dwyer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
Christopher J. Chan et al.
JOURNAL OF IMMUNOLOGY (2010)
High Expression of the Ectonucleotidase CD39 on T Cells from the Inflamed Site Identifies Two Distinct Populations, One Regulatory and One Memory T Cell Population
Halima Moncrieffe et al.
JOURNAL OF IMMUNOLOGY (2010)
Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas
Juliette Desfrancois et al.
PLOS ONE (2010)
Increased frequency of nonconventional double positive CD4CD8 αβ T cells in human breast pleural effusions
Juliette Desfrancois et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Human Follicular Lymphoma CD39+-Infiltrating T Cells Contribute to Adenosine-Mediated T Cell Hyporesponsiveness
Shannon P. Hilchey et al.
JOURNAL OF IMMUNOLOGY (2009)
CD28 costimulation is essential for human T regulatory expansion and function
Tatiana N. Golovina et al.
JOURNAL OF IMMUNOLOGY (2008)
Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma
BC Sheu et al.
CANCER RESEARCH (2005)
Share Paper
